Evidence map›Paper›PMID 38867588›Full record

ArticleHaematologica2024

Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells.

Jiro Kikuchi, Mitsuo Hori, Naoki Osada, Sae Matsuoka, Atsushi Suzuki, Satoshi Kakugawa, Hiroshi Yasui, Takeshi Harada, Hirofumi Tenshin, Masahiro Abe and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiro KikuchiDivision of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498. kiku-j@jichi.ac.jp.
Mitsuo HoriDepartment of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki 309-1793.
Naoki OsadaDivision of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498.
Sae MatsuokaDivision of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498.
Atsushi SuzukiOncology Division, Bristol-Myers Squibb K.K., Shinjuku, Tokyo 163-1327.
Satoshi KakugawaOncology Division, Bristol-Myers Squibb K.K., Shinjuku, Tokyo 163-1327.
Hiroshi YasuiThe Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511 Japan.
Takeshi HaradaDepartment of Hematology, University of Tokushima, Tokushima 770-8503.
Hirofumi TenshinDepartment of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8504.
Masahiro AbeDepartment of Hematology, Kawashima Hospital, Tokushima 770-0011.
Hideki NakasoneDivision of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498.
Yusuke FurukawaDivision of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan; Center for Medical Education, Teikyo University of Science, Tokyo 120-0045.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alternative SplicingMultiple MyelomaSignaling Lymphocytic Activation Molecule FamilyCell Line, TumorHumansSignaling Lymphocytic Activation Molecule FamilySLAMF7 protein, human

Identifiers

PMID38867588
PMCPMC11443410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.